{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T11:56:13Z","timestamp":1722513373747},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T00:00:00Z","timestamp":1380412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1756-0500-6-391","type":"journal-article","created":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T17:01:16Z","timestamp":1380474076000},"source":"Crossref","is-referenced-by-count":14,"title":["Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report"],"prefix":"10.1186","volume":"6","author":[{"given":"Magdy","family":"El-Salhy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Mazzawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Gundersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G","family":"Hatlebakk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trygve","family":"Hausken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,29]]},"reference":[{"key":"2411_CR1","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1007\/s10620-012-2249-6","volume":"57","author":"M El-Salhy","year":"2012","unstructured":"El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T: Chromogranin a cell density as a diagnostic marker for lymphocytic colitis. Dig Dis Sci. 2012, 57: 3154-3159. 10.1007\/s10620-012-2249-6.","journal-title":"Dig Dis Sci"},{"key":"2411_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0016-5085(95)90373-9","volume":"109","author":"L Agreus","year":"1995","unstructured":"Agreus L, Svardsudd K, Nyren O, Tibblin G: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995, 109: 671-680. 10.1016\/0016-5085(95)90373-9.","journal-title":"Gastroenterology"},{"key":"2411_CR3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0016-5085(80)90142-0","volume":"79","author":"WG Thompson","year":"1980","unstructured":"Thompson WG, Heaton KW: Functional bowel disorders in apparently healthy people. Gastroenterology. 1980, 79: 283-288.","journal-title":"Gastroenterology"},{"key":"2411_CR4","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/BF01303162","volume":"38","author":"DA Drossman","year":"1993","unstructured":"Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, et al: U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci. 1993, 38: 1569-1580. 10.1007\/BF01303162.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"2411_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5056\/jnm.2012.18.3.258","volume":"18","author":"R Spiller","year":"2012","unstructured":"Spiller R, Lam C: An update on post-infectious irritable bowel syndrome: role of genetics, immune activation, serotonin and altered microbiome. J Neurogastroenterol Motil. 2012, 18 (3): 258-268. 10.5056\/jnm.2012.18.3.258.","journal-title":"J Neurogastroenterol Motil"},{"key":"2411_CR6","first-page":"1970","volume":"98","author":"SD Parry","year":"2003","unstructured":"Parry SD, Stansfield R, Jelley D, Gregory W, Phillips E, Barton JR, Welfare MR: Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? a prospective, community-based, case\u2013control study. Am J Gastroenterol. 2003, 98: 1970-1975.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 3","key":"2411_CR7","doi-asserted-by":"publisher","first-page":"S285","DOI":"10.1086\/381598","volume":"38","author":"CR Friedman","year":"2004","unstructured":"Friedman CR, Hoekstra RM, Samuel M, Marcus R, Bender J, Shiferaw B, Reddy S, Ahuja SD, Helfrick DL, Hardnett F, et al: Risk factors for sporadic campylobacter infection in the United States: a case\u2013control study in foodnet sites. Clin Infect Dis. 2004, 38 (Suppl 3): S285-296.","journal-title":"Clin Infect Dis"},{"key":"2411_CR8","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1128\/JCM.30.12.3117-3121.1992","volume":"30","author":"G Kapperud","year":"1992","unstructured":"Kapperud G, Skjerve E, Bean NH, Ostroff SM, Lassen J: Risk factors for sporadic campylobacter infections: results of a case\u2013control study in southeastern Norway. J Clin Microbiol. 1992, 30: 3117-3121.","journal-title":"J Clin Microbiol"},{"key":"2411_CR9","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1053\/j.gastro.2009.02.074","volume":"136","author":"R Spiller","year":"2009","unstructured":"Spiller R, Garsed K: Postinfectious irritable bowel syndrome. Gastroenterology. 2009, 136: 1979-1988. 10.1053\/j.gastro.2009.02.074.","journal-title":"Gastroenterology"},{"issue":"7083","key":"2411_CR10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/bmj.314.7083.779","volume":"314","author":"KR Neal","year":"1997","unstructured":"Neal KR, Hebden J, Spiller R: Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ. 1997, 314 (7083): 779-782. 10.1136\/bmj.314.7083.779.","journal-title":"BMJ"},{"key":"2411_CR11","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/gut.47.6.804","volume":"47","author":"RC Spiller","year":"2000","unstructured":"Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000, 47: 804-811. 10.1136\/gut.47.6.804.","journal-title":"Gut"},{"issue":"8","key":"2411_CR12","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/gut.2003.021154","volume":"53","author":"LH Wang","year":"2004","unstructured":"Wang LH, Fang XC, Pan GZ: Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut. 2004, 53 (8): 1096-1101. 10.1136\/gut.2003.021154.","journal-title":"Gut"},{"key":"2411_CR13","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.2741\/E583","volume":"4","author":"M El-Salhy","year":"2012","unstructured":"El-Salhy M, Seim I, Chopin L, Gundersen D, Hatlebakk JG, Hausken T: Irritable bowel syndrome: the role of gut neuroendocrine peptides. Front Biosci (Elite Ed). 2012, 4: 2783-2800.","journal-title":"Front Biosci (Elite Ed)"},{"key":"2411_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s10620-011-1948-8","volume":"57","author":"M El-Salhy","year":"2012","unstructured":"El-Salhy M, Gundersen D, Ostgaard H, Lomholt-Beck B, Hatlebakk JG, Hausken T: Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci. 2012, 57: 873-878. 10.1007\/s10620-011-1948-8.","journal-title":"Dig Dis Sci"},{"key":"2411_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1542-3565(04)00726-8","volume":"3","author":"SP Dunlop","year":"2005","unstructured":"Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, Spiller RC: Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005, 3: 349-357. 10.1016\/S1542-3565(04)00726-8.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2411_CR16","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1053\/j.gastro.2003.09.028","volume":"125","author":"SP Dunlop","year":"2003","unstructured":"Dunlop SP, Jenkins D, Neal KR, Spiller RC: Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003, 125: 1651-1659. 10.1053\/j.gastro.2003.09.028.","journal-title":"Gastroenterology"},{"key":"2411_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1365-2982.2005.00719.x","volume":"17","author":"J Wheatcroft","year":"2005","unstructured":"Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R: Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil. 2005, 17: 863-870. 10.1111\/j.1365-2982.2005.00719.x.","journal-title":"Neurogastroenterol Motil"},{"key":"2411_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-230X-8-30","volume":"8","author":"AK Roalfe","year":"2008","unstructured":"Roalfe AK, Roberts LM, Wilson S: Evaluation of the Birmingham IBS symptom questionnaire. BMC gastroenterology. 2008, 8: 30-10.1186\/1471-230X-8-30.","journal-title":"BMC gastroenterology"},{"issue":"2","key":"2411_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1365-2036.2001.00900.x","volume":"15","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Verlinden M, Jones M: Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001, 15 (2): 207-216. 10.1046\/j.1365-2036.2001.00900.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"2411_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1023\/A:1018831127942","volume":"43","author":"DL Patrick","year":"1998","unstructured":"Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL: Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998, 43 (2): 400-411. 10.1023\/A:1018831127942.","journal-title":"Dig Dis Sci"},{"key":"2411_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4081\/gi.2010.e6","volume":"2","author":"M El-Salhy","year":"2010","unstructured":"El-Salhy M, Lillebo E, Reinemo A, Salmelid L, Hausken T: Effects of a health program comprising reassurance, diet management, probiotics administration and regular exercise on symptoms and quality of life in patients with irritable bowel syndrome. Gastroenterology insights. 2010, 2: 21-26.","journal-title":"Gastroenterology insights"},{"key":"2411_CR22","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3109\/00365521.2010.503965","volume":"45","author":"M El-Salhy","year":"2010","unstructured":"El-Salhy M, Lomholt-Beck B, Hausken T: Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol. 2010, 45: 1435-1439. 10.3109\/00365521.2010.503965.","journal-title":"Scand J Gastroenterol"},{"key":"2411_CR23","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3892\/mmr.2012.1087","volume":"6","author":"M El-Salhy","year":"2012","unstructured":"El-Salhy M, Mazzawi T, Gundersen D, Hausken T: Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Mol Med Report. 2012, 6: 1223-1225.","journal-title":"Mol Med Report"},{"issue":"4","key":"2411_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/BF00500540","volume":"92","author":"Y Cetin","year":"1989","unstructured":"Cetin Y, Muller-Koppel L, Aunis D, Bader MF, Grube D: Chromogranin A (CgA) in the gastro-entero-pancreatic (GEP) endocrine system II. CgA in mammalian entero-endocrine cells. Histochemistry. 1989, 92 (4): 265-275. 10.1007\/BF00500540.","journal-title":"Histochemistry"},{"key":"2411_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0047-6374(98)00154-7","volume":"108","author":"O Sandstrom","year":"1999","unstructured":"Sandstrom O, El-Salhy M: Ageing and endocrine cells of human duodenum. Mech Ageing Dev. 1999, 108: 39-48. 10.1016\/S0047-6374(98)00154-7.","journal-title":"Mech Ageing Dev"},{"key":"2411_CR26","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1007\/BF01303164","volume":"38","author":"AP Weston","year":"1993","unstructured":"Weston AP, Biddle WL, Bhatia PS, Miner PB: Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci. 1993, 38: 1590-1595. 10.1007\/BF01303164.","journal-title":"Dig Dis Sci"},{"key":"2411_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1046\/j.1365-2982.2000.00221.x","volume":"12","author":"M O\u2019Sullivan","year":"2000","unstructured":"O\u2019Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A, O\u2019Morain CA: Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil. 2000, 12: 449-457. 10.1046\/j.1365-2982.2000.00221.x.","journal-title":"Neurogastroenterol Motil"},{"key":"2411_CR28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2036.2010.04251.x","volume":"31","author":"V Dizdar","year":"2010","unstructured":"Dizdar V, Spiller R, Singh G, Hanevik K, Gilja OH, El-Salhy M, Hausken T: Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2010, 31: 883-891.","journal-title":"Aliment Pharmacol Ther"},{"key":"2411_CR29","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1111\/j.1572-0241.2003.07542.x","volume":"98","author":"SP Dunlop","year":"2003","unstructured":"Dunlop SP, Jenkins D, Spiller RC: Distinctive clinical, pyschological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol. 2003, 98: 1578-1583. 10.1111\/j.1572-0241.2003.07542.x.","journal-title":"Am J Gastroenterol"},{"key":"2411_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3349\/ymj.2010.51.1.45","volume":"51","author":"HS Kim","year":"2010","unstructured":"Kim HS, Lim JH, Park H, Lee SI: Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection- an observation in a small case control study. Younsei Med J. 2010, 51: 45-51. 10.3349\/ymj.2010.51.1.45.","journal-title":"Younsei Med J"},{"key":"2411_CR31","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/j.1440-1746.2008.05574.x","volume":"23","author":"KJ Lee","year":"2008","unstructured":"Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW: The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol. 2008, 23: 1689-1694. 10.1111\/j.1440-1746.2008.05574.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"2411_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1078\/0065-1281-00641","volume":"104","author":"II Stoyanova","year":"2002","unstructured":"Stoyanova II, Gulubova MV: Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta histochemica. 2002, 104 (2): 185-192. 10.1078\/0065-1281-00641.","journal-title":"Acta histochemica"},{"key":"2411_CR33","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2004.03.013","volume":"126","author":"MD Coates","year":"2004","unstructured":"Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, et al: Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004, 126: 1657-1664. 10.1053\/j.gastro.2004.03.013.","journal-title":"Gastroenterology"},{"issue":"1","key":"2411_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2169\/internalmedicine1962.27.49","volume":"27","author":"A Tari","year":"1988","unstructured":"Tari A, Teshima H, Sumii K, Haruma K, Ohgoshi H, Yoshihara M, Kajiyama G, Miyachi Y: Peptide YY abnormalities in patients with ulcerative colitis. Japanese journal of medicine. 1988, 27 (1): 49-55. 10.2169\/internalmedicine1962.27.49.","journal-title":"Japanese journal of medicine"},{"issue":"42","key":"2411_CR35","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.3748\/wjg.v18.i42.6070","volume":"18","author":"M El-Salhy","year":"2012","unstructured":"El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T: High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis. World J Gastroenterol. 2012, 18 (42): 6070-6075. 10.3748\/wjg.v18.i42.6070.","journal-title":"World J Gastroenterol"},{"key":"2411_CR36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2249.2010.04150.x","volume":"161","author":"WI Khan","year":"2010","unstructured":"Khan WI, Ghia JE: Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol. 2010, 161: 19-27.","journal-title":"Clin Exp Immunol"},{"key":"2411_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","volume":"132","author":"MD Gershon","year":"2007","unstructured":"Gershon MD, Tack J: The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007, 132: 397-414. 10.1053\/j.gastro.2006.11.002.","journal-title":"Gastroenterology"},{"key":"2411_CR38","doi-asserted-by":"crossref","first-page":"G838","DOI":"10.1152\/ajpcell.1992.263.4.C838","volume":"263","author":"JF Tack","year":"1992","unstructured":"Tack JF, Janssens J, Vantrappen G, Wood JD: Actions of 5-hydroxytryptamine on myenteric neurons in guinea pig gastric antrum. Am J Physiol. 1992, 263: G838-846.","journal-title":"Am J Physiol"},{"key":"2411_CR39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.coph.2003.07.005","volume":"3","author":"MD Gershon","year":"2003","unstructured":"Gershon MD: Plasticity in serotonin control mechanisms in the gut. Curr Opin Pharmacol. 2003, 3: 600-607. 10.1016\/j.coph.2003.07.005.","journal-title":"Curr Opin Pharmacol"},{"key":"2411_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/MED.0b013e32835bc703","volume":"20","author":"MD Gershon","year":"2013","unstructured":"Gershon MD: 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013, 20: 14-21. 10.1097\/MED.0b013e32835bc703.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2411_CR41","first-page":"268","volume":"123","author":"MD Gershon","year":"2012","unstructured":"Gershon MD: Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense. Trans Am Clin Climatol Assoc. 2012, 123: 268-280. discussion 280","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"2411_CR42","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1523\/JNEUROSCI.17-20-08009.1997","volume":"17","author":"K Michel","year":"1997","unstructured":"Michel K, Sann H, Schaaf C, Schemann M: Subpopulations of gastric myenteric neurons are differentially activated via distinct serotonin receptors: projection, neurochemical coding, and functional implications. J Neurosci. 1997, 17: 8009-8017.","journal-title":"J Neurosci"},{"key":"2411_CR43","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/gut.25.4.365","volume":"25","author":"RC Spiller","year":"1984","unstructured":"Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ, Silk DB: The ileal brake\u2013inhibition of jejunal motility after ileal fat perfusion in man. Gut. 1984, 25: 365-374. 10.1136\/gut.25.4.365.","journal-title":"Gut"},{"key":"2411_CR44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0016-5085(84)90411-6","volume":"86","author":"NW Read","year":"1984","unstructured":"Read NW, McFarlane A, Kinsman RI, Bates TE, Blackhall NW, Farrar GB, Hall JC, Moss G, Morris AP, O\u2019Neill B, et al: Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology. 1984, 86: 274-280.","journal-title":"Gastroenterology"},{"key":"2411_CR45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/mol.60.1.124","volume":"60","author":"M Goumain","year":"2001","unstructured":"Goumain M, Voisin T, Lorinet AM, Ducroc R, Tsocas A, Roze C, Rouet-Benzineb P, Herzog H, Balasubramaniam A, Laburthe M: The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning. Mol Pharmacol. 2001, 60: 124-134.","journal-title":"Mol Pharmacol"},{"key":"2411_CR46","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0196-9781(97)00069-7","volume":"18","author":"A Souli","year":"1997","unstructured":"Souli A, Chariot J, Voisin T, Presset O, Tsocas A, Balasubramaniam A, Laburthe M, Roze C: Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo. Peptides. 1997, 18: 551-557. 10.1016\/S0196-9781(97)00069-7.","journal-title":"Peptides"},{"key":"2411_CR47","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1023\/A:1018869116284","volume":"42","author":"EE Whang","year":"1997","unstructured":"Whang EE, Hines OJ, Reeve JR, Grandt D, Moser JA, Bilchik AJ, Zinner MJ, McFadden DW, Ashley SW: Antisecretory mechanisms of peptide YY in rat distal colon. Dig Dis Sci. 1997, 42: 1121-1127. 10.1023\/A:1018869116284.","journal-title":"Dig Dis Sci"},{"key":"2411_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.peptides.2009.11.005","volume":"31","author":"R Moriya","year":"2010","unstructured":"Moriya R, Shirakura T, Hirose H, Kanno T, Suzuki J, Kanatani A: NPY Y2 receptor agonist PYY(3\u201336) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice. Peptides. 2010, 31: 671-675. 10.1016\/j.peptides.2009.11.005.","journal-title":"Peptides"},{"issue":"3","key":"2411_CR49","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1053\/j.gastro.2004.12.006","volume":"128","author":"DA Drossman","year":"2005","unstructured":"Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI: A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology. 2005, 128 (3): 580-589. 10.1053\/j.gastro.2004.12.006.","journal-title":"Gastroenterology"},{"issue":"2","key":"2411_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00042737-200302000-00010","volume":"15","author":"F Mearin","year":"2003","unstructured":"Mearin F, Balboa A, Badia X, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, et al: Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol. 2003, 15 (2): 165-172. 10.1097\/00042737-200302000-00010.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2411_CR51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1572-0241.2003.04023.x","volume":"99","author":"F Mearin","year":"2004","unstructured":"Mearin F, Baro E, Roset M, Badia X, Zarate N, Perez I: Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol. 2004, 99: 113-121. 10.1046\/j.1572-0241.2003.04023.x.","journal-title":"Am J Gastroenterol"},{"key":"2411_CR52","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1365-2036.2008.03813.x","volume":"28","author":"AC Ford","year":"2008","unstructured":"Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P: Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. Aliment Pharmacol Ther. 2008, 28: 1013-1020. 10.1111\/j.1365-2036.2008.03813.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"2411_CR53","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1055\/s-2007-1021624","volume":"14","author":"P Rutgeerts","year":"1982","unstructured":"Rutgeerts P, Geboes K, Ponette E, Coremans G, Vantrappen G: Acute infective colitis caused by endemic pathogens in western Europe: endoscopic features. Endoscopy. 1982, 14: 212-219. 10.1055\/s-2007-1021624.","journal-title":"Endoscopy"},{"key":"2411_CR54","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/01.psy.0000221384.07521.05","volume":"68","author":"R Moss-Morris","year":"2006","unstructured":"Moss-Morris R, Spence M: To \"lump\" or to \"split\" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome?. Psychosom Med. 2006, 68: 463-469. 10.1097\/01.psy.0000221384.07521.05.","journal-title":"Psychosom Med"},{"key":"2411_CR55","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/gut.2006.108811","volume":"56","author":"MJ Spence","year":"2007","unstructured":"Spence MJ, Moss-Morris R: The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis. Gut. 2007, 56: 1066-1071. 10.1136\/gut.2006.108811.","journal-title":"Gut"},{"key":"2411_CR56","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1053\/j.gastro.2006.05.053","volume":"131","author":"JK Marshall","year":"2006","unstructured":"Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM: Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology. 2006, 131: 445-450. 10.1053\/j.gastro.2006.05.053. quiz 660","journal-title":"Gastroenterology"},{"key":"2411_CR57","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2036.2008.03884.x","volume":"29","author":"EM Quigley","year":"2009","unstructured":"Quigley EM, Vandeplassche L, Kerstens R, Ausma J: Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation\u2013a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009, 29: 315-328. 10.1111\/j.1365-2036.2008.03884.x.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-6-391.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-0500-6-391\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-6-391.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T07:38:18Z","timestamp":1716017898000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-6-391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,29]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2411"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-6-391","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,29]]},"article-number":"391"}}